Advisors Asset Management, Inc. Ionis Pharmaceuticals Inc Transaction History

Advisors Asset Management, Inc.

$5.1 Billion
Q1 2024

A detailed history of Advisors Asset Management, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 3,178 shares of IONS stock, worth $144,916. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,178

Previous 303 948.84%

Holding current value

$144,916

Previous $15,000 813.33%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$42.03 - $53.55 $120,836 - $153,956	2,875 Added 948.84%	3,178 $137,000
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $13,147 - $15,643	303 New	303 $15,000
Q4 2021 Feb 15, 2022	SELL	$25.61 - $35.1 $81,030 - $111,056	-3,164 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$33.54 - $40.55 $503 - $608	-15 Reduced 0.47%	3,164 $106,000
Q2 2021 Jul 30, 2021	SELL	$34.54 - $47.25 $1,001 - $1,370	-29 Reduced 0.9%	3,179 $127,000

Q1 2021 May 07, 2021	SELL	$42.51 - $63.78 $288,727 - $433,193	-6,792 Reduced 67.92%	3,208 $144,000
Q4 2020 Feb 12, 2021	SELL	$45.3 - $60.27 $302,739 - $402,784	-6,683 Reduced 40.06%	10,000 $565,000
Q3 2020 Nov 16, 2020	SELL	$47.45 - $62.95 $42,894 - $56,906	-904 Reduced 5.14%	16,683 $792,000
Q2 2020 Aug 12, 2020	SELL	$46.85 - $61.05 $11,525 - $15,018	-246 Reduced 1.38%	17,587 $1.04 Million
Q1 2020 May 15, 2020	BUY	$41.6 - $63.4 $57,033 - $86,921	1,371 Added 8.33%	17,833 $843,000
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $136,725 - $165,720	-2,539 Reduced 13.36%	16,462 $994,000
Q3 2019 Nov 14, 2019	SELL	$59.06 - $72.15 $351,111 - $428,931	-5,945 Reduced 23.83%	19,001 $1.14 Million
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $226,442 - $314,152	-3,647 Reduced 12.75%	24,946 $1.6 Million
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $388,326 - $595,625	7,338 Added 34.52%	28,593 $2.32 Million
Q4 2018 Jan 31, 2019	BUY	$43.37 - $59.54 $107,644 - $147,778	2,482 Added 13.22%	21,255 $1.15 Million
Q3 2018 Nov 15, 2018	SELL	$42.88 - $53.7 $29,201 - $36,569	-681 Reduced 3.5%	18,773 $968,000
Q2 2018 Aug 22, 2018	SELL	$40.53 - $50.7 $2.62 Million - $3.28 Million	-64,702 Reduced 76.88%	19,454 $811,000
Q2 2018 Aug 15, 2018	BUY	$40.53 - $50.7 $2.31 Million - $2.89 Million	57,068 Added 210.68%	84,156 $811,000
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $32,575 - $40,681	739 Added 2.8%	27,088 $1.43 Million
Q4 2017 Feb 13, 2018	BUY	$50.3 - $64.39 $437,459 - $559,999	8,697 Added 49.27%	26,349 $1.33 Million
Q3 2017 Nov 07, 2017	BUY	$45.56 - $59.57 $804,225 - $1.05 Million	17,652	17,652 $895,000

Others Institutions Holding IONS

# of Institutions

397

Shares Held

122M

Call Options Held

854K

Put Options Held

464K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $6.47B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Ionis Pharmaceuticals Inc Transaction History